14 Recruiting Hematologic Neoplasms Clinical Trials
Explore open interventional and observational research studies actively enrolling participants across the USA. Verify eligibility and contact site coordinators directly.
📍 Find Near Me by DistanceBrowse by Study Phase
Top Interventions for Hematologic Neoplasms
Top Recruiting Hematologic Neoplasms Studies
🔵 Active, Not Recruiting Observational / Diagnostic ⚙️ Medical Device Protocol
Comparison of Hemanext ONE® System and Conventional Red Blood Cell Transfusion
📍 Duke University Health System — Durham, North Carolina
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase2 📋 Clinical Research Protocol
Fludarabine and Total Body Irradiation 800 Centigray (cGy) or 1125 cGy For Allogeneic Stem Cell Transplant Using Graft Versus Host Disease Prophylaxis With Post-Transplant Cyclophosphamide and Tacrolimus, Without Mycophenolate Mofetil
📍 Cedars-Sinai Medical Center — Los Angeles, California
View Study & Checklist ➔ 🟢 Recruiting Phase1 / Phase2 💊 Investigational Drug / Biologic
A Phase 1/2 Study of KK2430 in Participants With Hematologic Neoplasms
📍 Prisma Health — Greenville, South Carolina
View Study & Checklist ➔ 🟢 Recruiting Phase3 💊 Investigational Drug / Biologic
Platelet Transfusions in Hematopoietic Stem Cell Transplantation (The PATH III Trial)
📍 Tom Baker Cancer Centre — Calgary, Alberta
View Study & Checklist ➔ 🟢 Recruiting Phase1 💊 Investigational Drug / Biologic
A Study of JNJ-95804306 for Relapsed or Refractory Hematological Malignancies
📍 Indiana Blood & Marrow Transplantation — Indianapolis, Indiana
View Study & Checklist ➔ 🟢 Recruiting Phase1 / Phase2 💊 Investigational Drug / Biologic
Donor Lymphocyte Infusion After Allogeneic Hematopoietic Cell Transplantation for High-Risk Hematologic Malignancies
📍 National Institutes of Health Clinical Center — Bethesda, Maryland
View Study & Checklist ➔ 🟢 Recruiting Interventional Protocol 📊 Observational Clinical Research
UWCCC Molecular Tumor Board Registry
📍 University of Wisconsin Carbone Cancer Center — Madison, Wisconsin
View Study & Checklist ➔ 🟢 Recruiting Phase1 / Phase2 💊 Investigational Drug / Biologic
Phase I/II Study to Reduce Post-transplantation Cyclophosphamide Dosing for Older or Unfit Patients Undergoing Bone Marrow Transplantation for Hematologic Malignancies
📍 National Institutes of Health Clinical Center — Bethesda, Maryland
View Study & Checklist ➔